Is ABBV or TMO cheaper?

On trailing earnings, TMO is cheaper: ABBV trades at a 111.67 P/E and TMO at 25.80.

Which has grown faster, ABBV or TMO?

Over the past five years, TMO grew revenue faster — ABBV at a 4.59% CAGR versus TMO at 6.68%.

Does ABBV or TMO pay a bigger dividend?

ABBV yields 2.96% and TMO yields 0.28% based on trailing dividends and the latest price.

Is ABBV or TMO more profitable?

TMO runs the higher net margin — ABBV at 5.79% versus TMO at 15.18%.

Which has been the better investment, ABBV or TMO?

Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus TMO at 12.26%. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Thermo Fisher Scientific Inc. (TMO)

ABBV and TMO are evenly matched — 7 metrics each of 14.

A side-by-side comparison of AbbVie Inc. and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Thermo Fisher Scientific Inc.

$174.42B

$469.34Healthcare

Total return — ABBV vs TMO

growth of $100 · last 14y

ABBV +550.7%TMO +624.5%TMO compounded faster

ABBV TMO

ABBV vs TMO: by the numbers

•ABBV is the larger company ($402.35B vs $174.42B market cap).
•TMO trades at the lower earnings multiple (25.80 vs 111.67 P/E).
•TMO converts more revenue to profit (15.18% vs 5.79% net margin).
•TMO grew revenue faster over the past five years (6.68% vs 4.59% CAGR).
•ABBV pays the higher dividend yield (2.96% vs 0.28%).

Which is better, ABBV or TMO?

Metric tally: ABBV 7 · TMO 7

It depends on what you're optimizing for:

ValueTMO(lower P/E)

GrowthTMO(faster 5Y revenue CAGR)

IncomeABBV(higher dividend yield)

QualityABBV(higher ROIC)

Valuation

Metric	ABBV	TMO
P/E ratio	111.67	25.80●
Forward P/E	—	17.26
P/S ratio	6.43	3.87●
P/B ratio	14.69	3.37●
PEG ratio	—	4.51
EV / EBITDA	27.63	19.26●
FCF yield	5.17%●	3.86%

Profitability

Metric	ABBV	TMO
Gross margin	70.68%●	39.41%
Operating margin	27.60%●	17.76%
Net margin	5.79%	15.18%●
ROE	13.23%	13.21%
ROIC	12.97%●	7.58%

Dividends

Metric	ABBV	TMO
Dividend yield	2.96%●	0.28%
Payout ratio	284.39%	7.48%

Growth (annualized)

Metric	ABBV	TMO
Revenue CAGR (5Y)	4.59%	6.68%●
EPS CAGR (5Y)	-2.79%	1.99%●
FCF CAGR (5Y)	3.24%●	-0.19%
Total return CAGR (5Y)	18.95%●	0.45%

Frequently asked

Which is better, ABBV or TMO?: It depends on your goal. value: TMO (lower P/E); growth: TMO (faster 5Y revenue CAGR); income: ABBV (higher dividend yield); quality: ABBV (higher ROIC). Across all compared metrics, they are evenly matched.
Is ABBV or TMO cheaper?: On trailing earnings, TMO is cheaper: ABBV trades at a 111.67 P/E and TMO at 25.80.
Which has grown faster, ABBV or TMO?: Over the past five years, TMO grew revenue faster — ABBV at a 4.59% CAGR versus TMO at 6.68%.
Does ABBV or TMO pay a bigger dividend?: ABBV yields 2.96% and TMO yields 0.28% based on trailing dividends and the latest price.
Is ABBV or TMO more profitable?: TMO runs the higher net margin — ABBV at 5.79% versus TMO at 15.18%.
Which has been the better investment, ABBV or TMO?: Over the past 10-year, ABBV delivered the higher annualized total return — ABBV at 18.88% versus TMO at 12.26%. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Thermo Fisher Scientific P/E ratio AbbVie dividend yield Thermo Fisher Scientific dividend yield AbbVie ROE Thermo Fisher Scientific ROE AbbVie operating margin Thermo Fisher Scientific operating margin AbbVie revenue growth Thermo Fisher Scientific revenue growth AbbVie free cash flow Thermo Fisher Scientific free cash flow

AbbVie & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks Dividend Aristocrats Highest FCF Yield Stocks Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.